Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

European Pharmaceutical Pricing And Reimbursement Conference, 29-30 October 2012, London, UK

Date: Aug-20-2012
SMi's 18th annual European Pharmaceutical Pricing and Reimbursement conference on 29th & 30th October 2012, will bring together industry experts from a range of industry and international perspectives; each providing a different viewpoint on the subject. This leading event will present attendees with solutions and strategies within key issues such as market access strategies, recent developments in the healthcare landscape and challenges in VBP and the effects of the AMNOG. This event will act as a unique forum for attendees to learn, make connections and explore new ideas.

BENEFITS OF ATTENDING:
Hear from experts in the field on Value Based Pricing: Principles and practice
Debate EU policy challenges in access to medicines in Europe with experts from Germany, Italy, UK, Switzerland and Belgium
Analyse market access in Russia, Turkey and Eastern Europe
Learn about the latest regulations within pricing and reimbursement from industry
Understand the facts and consequences of Germany's AMNOG
Discover the value of collaboration in HTA and managed entry schemes
Consider an international view with perspectives from the Asia-Pac Region and North America
Network with and learn from senior industry representatives from companies such as Sanofi, GSK, Abbott and UCB

HEAR KEY PRESENTATIONS FROM EXPERTS IN THE FIELD:



Value and patient access considerations: a possible framework for improving access to rare disease treatments

Pierrick Rollet, VP, Global Market Access, GlaxoSmithKline

Implementing HTA in Switzerland - A Multi-Stakeholder Approach

Thilo Schaufler, Head of Market Access and Governmental Affairs, Abbott

Update on Healthcare Reform in the Russia Federation

Timothy Lenehan, Market Access Director, UCB Pharma



Risk-Sharing: Developing a commercial strategy

Anant Murthy, Senior Director,

Pricing and Market Access, EMEA,
Celgene



Pricing and Reimbursement system in Turkey

Toros Sahin, Market Access Manager, Sanofi

Trends in HTA - What is happening where?

Janice Haigh, Practice Leader, Market Access Europe, Quintiles

Visit http://www.smi-online.co.uk/goto/2012europricing32.asp to secure your place now! Alternatively, contact Alternatively Contact Fateja Begum on telephone +44 (0) 20 7827 6184 or email on fbegum@smi-online.co.uk

Courtesy: Medical News Today
Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.